<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">35229710</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>04</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>16</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1469-4409</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>150</Volume>
            <PubDate>
              <Year>2022</Year>
              <Month>Jan</Month>
              <Day>13</Day>
            </PubDate>
          </JournalIssue>
          <Title>Epidemiology and infection</Title>
          <ISOAbbreviation>Epidemiol Infect</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Leveraging serology to titrate immunisation programme functionality for diphtheria in Madagascar.</ArticleTitle>
        <Pagination>
          <StartPage>e39</StartPage>
          <MedlinePgn>e39</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">e39</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1017/S0950268822000097</ELocationID>
        <Abstract>
          <AbstractText>Diphtheria is a potentially devastating disease whose epidemiology remains poorly described in many settings, including Madagascar. Diphtheria vaccination is delivered in combination with pertussis and tetanus antigens and coverage of this vaccine is often used as a core measure of health system functioning. However, coverage is challenging to estimate due to the difficulty in translating numbers of doses delivered into numbers of children effectively immunised. Serology provides an alternative lens onto immunisation, but is complicated by challenges in discriminating between natural and vaccine-derived seropositivity. Here, we leverage known features of the serological profile of diphtheria to bound expectations for vaccine coverage for diphtheria, and further refine these using serology for pertussis. We measured diphtheria antibody titres in 185 children aged 6-11 months and 362 children aged 8-15 years and analysed them with pertussis antibody titres previously measured for each individual. Levels of diphtheria seronegativity varied among age groups (18.9% of children aged 6-11 months old and 11.3% of children aged 8-15 years old were seronegative) and also among the districts. We also find surprisingly elevated levels of individuals seropositive to diphtheria but not pertussis in the 6-11 month old age group suggesting that vaccination coverage or efficacy of the pertussis component of the DTP vaccine remains low or that natural infection of diphtheria may be playing a significant role in seropositivity in Madagascar.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Razafimahatratra</LastName>
            <ForeName>Solohery L</ForeName>
            <Initials>SL</Initials>
            <AffiliationInfo>
              <Affiliation>Immunology of Infectious Diseases Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Experimental Bacteriology Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Menezes</LastName>
            <ForeName>Arthur</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0002-0195-4071</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wesolowski</LastName>
            <ForeName>Amy</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0001-6320-3575</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rafetrarivony</LastName>
            <ForeName>Lala</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Experimental Bacteriology Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cauchemez</LastName>
            <ForeName>Simon</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Mathematical Modelling of Infectious Diseases Unit, Institut Pasteur, UMR 2000, CNRS, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Razafindratsimandresy</LastName>
            <ForeName>Richter</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Virology Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Harimanana</LastName>
            <ForeName>Aina</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Epidemiology and Clinical Research Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Crucitti</LastName>
            <ForeName>Tania</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Experimental Bacteriology Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Collard</LastName>
            <ForeName>Jean Marc</ForeName>
            <Initials>JM</Initials>
            <AffiliationInfo>
              <Affiliation>Experimental Bacteriology Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Center for Microbes, Development and Health (CMDH), Institut Pasteur of Shanghai/Chinese Academy of Sciences, Shanghai, China (Current Address).</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Metcalf</LastName>
            <ForeName>C J E</ForeName>
            <Initials>CJE</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Princeton School of Public and International Affairs, Princeton University, Princeton, NJ, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <Acronym>WT_</Acronym>
            <Agency>Wellcome Trust</Agency>
            <Country>United Kingdom</Country>
          </Grant>
          <Grant>
            <GrantID>106866/Z/15/Z</GrantID>
            <Acronym>WT_</Acronym>
            <Agency>Wellcome Trust</Agency>
            <Country>United Kingdom</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>01</Month>
          <Day>13</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Epidemiol Infect</MedlineTA>
        <NlmUniqueID>8703737</NlmUniqueID>
        <ISSNLinking>0950-2688</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000907">Antibodies, Bacterial</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D015721">Diphtheria-Tetanus-Pertussis Vaccine</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000907" MajorTopicYN="N">Antibodies, Bacterial</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001886" MajorTopicYN="N">Bordetella pertussis</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003353" MajorTopicYN="N">Corynebacterium diphtheriae</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004165" MajorTopicYN="N">Diphtheria</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
          <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015721" MajorTopicYN="N">Diphtheria-Tetanus-Pertussis Vaccine</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017589" MajorTopicYN="Y">Immunization Programs</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008270" MajorTopicYN="N" Type="Geographic">Madagascar</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016036" MajorTopicYN="N">Seroepidemiologic Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000073887" MajorTopicYN="N">Vaccination Coverage</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014917" MajorTopicYN="N">Whooping Cough</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
          <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Diphtheria</Keyword>
        <Keyword MajorTopicYN="Y">Madagascar</Keyword>
        <Keyword MajorTopicYN="Y">pertussis</Keyword>
        <Keyword MajorTopicYN="Y">serology</Keyword>
      </KeywordList>
      <CoiStatement>The authors have no conflicts of interest to report.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>1</Day>
          <Hour>8</Hour>
          <Minute>41</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35229710</ArticleId>
        <ArticleId IdType="pmc">PMC8888278</ArticleId>
        <ArticleId IdType="doi">10.1017/S0950268822000097</ArticleId>
        <ArticleId IdType="pii">S0950268822000097</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Clarke KEN
et al. (2019) Global Epidemiology of Diphtheria, 2000–2017. Emerging Infectious Diseases
25, 1834–1842.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6759252</ArticleId>
            <ArticleId IdType="pubmed">31538559</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Truelove SA
et al. (2020) Clinical and epidemiological aspects of diphtheria: a systematic review and pooled analysis. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America
71, 89–97.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7312233</ArticleId>
            <ArticleId IdType="pubmed">31425581</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arguni E
et al. (2021) Diphtheria outbreak in Jakarta and tangerang, Indonesia: epidemiological and clinical predictor factors for death. PLoS ONE
16, e0246301.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7861411</ArticleId>
            <ArticleId IdType="pubmed">33539453</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mosser JF
et al. (2019) Mapping diphtheria-pertussis-tetanus vaccine coverage in Africa, 2000–2016: a spatial and temporal modelling study. The Lancet
393, 1843–1855.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6497987</ArticleId>
            <ArticleId IdType="pubmed">30961907</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Finger F
et al. (2019) Real-time analysis of the diphtheria outbreak in forcibly displaced Myanmar nationals in Bangladesh. BMC Medicine
17, 58.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6413455</ArticleId>
            <ArticleId IdType="pubmed">30857521</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mahomed S
et al. (2017) An isolated outbreak of diphtheria in South Africa, 2015. Epidemiology and Infection
145, 2100–2108.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28478776</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jané M
et al. (2018) A case of respiratory toxigenic diphtheria: contact tracing results and considerations following a 30-year disease-free interval, Catalonia, Spain, 2015. Euro surveillance: bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
23, 1–6. doi: 10.2807/1560-7917.ES.2018.23.13.17-00183.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2807/1560-7917.ES.2018.23.13.17-00183</ArticleId>
            <ArticleId IdType="pmc">PMC5883453</ArticleId>
            <ArticleId IdType="pubmed">29616610</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wagner KS
et al. (2010) Diphtheria in the United Kingdom, 1986–2008: the increasing role of Corynebacterium ulcerans. Epidemiology and Infection
138, 1519–1530.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20696088</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Belchior E
et al. (2017) Diphtheria in Mayotte, 2007–2015. Emerging Infectious Diseases
23, 1218–1220.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5512491</ArticleId>
            <ArticleId IdType="pubmed">28628446</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rakotomalala RS
et al. (2021) Corynebacterium diphtheriae infection in Mahajanga, Madagascar: first case report. Journal of Tropical Pediatrics
67, 1–4. doi: 10.1093/tropej/fmaa064.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/tropej/fmaa064</ArticleId>
            <ArticleId IdType="pubmed">33094342</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ministry of Health and Ministry of Health and Family Planning- Vaccination Department. Complete Multi-Year Plan Expanded Immunization Program 2010–2014.</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization (2017) The immunological basis for immunization series: module 4: pertussis. World Health Organization.</Citation>
        </Reference>
        <Reference>
          <Citation>Cutts FT and Hanson M (2016) Seroepidemiology: an underused tool for designing and monitoring vaccination programmes in low- and middle-income countries. Tropical Medicine &amp; International Health: TM &amp; IH
21, 1086–1098.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27300255</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>World Health Organization (2009) Immunological basis for immunization: module 2: diphtheria – update 2009. World Health Organization.</Citation>
        </Reference>
        <Reference>
          <Citation>Antia A
et al. (2018) Heterogeneity and longevity of antibody memory to viruses and vaccines. PLoS Biology
16, e2006601.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6105026</ArticleId>
            <ArticleId IdType="pubmed">30096134</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barr M, Glenny AT and Randall KJ (1949) Concentration of diphtheria antitoxin in cord blood and rate of loss in babies. The Lancet
2, 324–326.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18137352</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tiwari TSP and Wharton M (2018) Diphtheria toxoid. In Stanley AP, Walter AO, Paul AO and Kathryn ME (eds), Plotkin's Vaccines. Amsterdam, The Netherlands: Elsevier, pp. 261–275.</Citation>
        </Reference>
        <Reference>
          <Citation>Razafindratsimandresy R
et al. (2018) Assessment of poliovirus antibody seroprevalence in high-risk areas for vaccine-derived poliovirus transmission in Madagascar. Heliyon
4, e00563.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5857717</ArticleId>
            <ArticleId IdType="pubmed">29560473</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Razafimahatratra SL
et al. (2020) Seroprevalence of pertussis in Madagascar and implications for vaccination. Epidemiology and Infection
148, e283.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7770380</ArticleId>
            <ArticleId IdType="pubmed">33190665</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zasada AA
et al. (2013) Comparison of seven commercial enzyme-linked immunosorbent assays for the detection of anti-diphtheria toxin antibodies. European Journal of Clinical Microbiology &amp; Infectious Diseases: Official Publication of the European Society of Clinical Microbiology
32, 891–897.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23354678</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ipsen J (1946) Circulating antitoxin at the onset of diphtheria in 425 patients. Journal of Immunology
54, 325–347.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20278364</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Björkholm B
et al. (1986) Antitoxin antibody levels and the outcome of illness during an outbreak of diphtheria among alcoholics. Scandinavian Journal of Infectious Diseases
18, 235–239.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3738434</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Danilova E
et al. (2006) Antidiphtheria antibody responses in patients and carriers of Corynebacterium diphtheriae in the Arkhangelsk region of Russia. Clinical and Vaccine Immunology: CVI
13, 627–632.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1489558</ArticleId>
            <ArticleId IdType="pubmed">16760319</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ohuabunwo C
et al. (2005) Respiratory diphtheria among highly vaccinated military trainees in Latvia: improved protection from DT compared with Td booster vaccination. Scandinavian Journal of Infectious Diseases
37, 813–820.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16308214</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Efstratiou A, Maple CPA, World Health Organization and Regional Office for Europe (1994) Laboratory diagnosis of diphtheria/by Androulla Efstratiou and P. A. Christopher Maple. Copenhagen: WHO Regional Office for Europe. Report No.: ICP/EPI 038(C).</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization (2017) Review of evidence on vaccine effectiveness and immunogenicity to assess the duration of protection ⩾10 years after the last booster dose.</Citation>
        </Reference>
        <Reference>
          <Citation>Walory J, Grzesiowski P and Hryniewicz W (2000) Comparison of four serological methods for the detection of diphtheria anti-toxin antibody. Journal of Immunological Methods
245, 55–65.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11042283</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burton A
et al. (2009) WHO and UNICEF estimates of national infant immunization coverage: methods and processes. Bulletin of the World Health Organization
87, 535–541.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2704038</ArticleId>
            <ArticleId IdType="pubmed">19649368</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sheridan SL
et al. (2014) Waning vaccine immunity in teenagers primed with whole-cell and acellular pertussis vaccine: recent epidemiology. Expert Review of Vaccines
13, 1081–1106.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25093268</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>World Health Organization (2015) Whole-Cell Pertussis Vaccines Summary of evidence relevant to schedules. Available at https://www.who.int/immunization/sage/meetings/2015/april/2_wP_summary_WG_23Mar2015_submitted.pdf?ua= (Accessed 31 August 2021).</Citation>
        </Reference>
        <Reference>
          <Citation>Healy CM
et al. (2020) Kinetics of maternal pertussis-specific antibodies in infants of mothers vaccinated with tetanus, diphtheria and acellular pertussis (Tdap) during pregnancy. Vaccine
38, 5955–5961.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32709433</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anderson EL, Belshe RB and Bartram J (1988) Differences in reactogenicity and antigenicity of acellular and standard pertussis vaccines combined with diphtheria and tetanus in infants. The Journal of Infectious Diseases
157, 731–737.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2894399</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cherian T
et al. (2002) Safety and immunogenicity of Haemophilus influenzae type B vaccine given in combination with DTwP at 6, 10 and 14 weeks of age. Indian Pediatrics, 39, 427–436.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12037271</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Centers for Disease Control and Prevention (2021) About Diphtheria, Tetanus, and Pertussis Vaccination. Available at https://www.cdc.gov/vaccines/vpd/dtap-tdap-td/hcp/about-vaccine.html (Accessed 16 September 2021).</Citation>
        </Reference>
        <Reference>
          <Citation>Guiso N (2014) Bordetella pertussis: why is it still circulating?
The Journal of Infection
68(suppl. 1), S119–S124.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24103807</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fulton TR
et al. (2016) Protective effect of contemporary Pertussis vaccines: a systematic review and meta-analysis. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
62, 1100–1110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4826451</ArticleId>
            <ArticleId IdType="pubmed">26908803</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wilkins J, Chan LS and Wehrle PF (1987) Age and dose interval as factors in agglutinin formation to pertussis vaccine. Vaccine
5, 49–54.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2883784</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lessler J
et al. (2011) Measuring the performance of vaccination programs using cross-sectional surveys: a likelihood framework and retrospective analysis. PLoS Medicine
8, e1001110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3201935</ArticleId>
            <ArticleId IdType="pubmed">22039353</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meng Q
et al. (2018) Seroprevalence of diphtheria and pertussis immunoglobulin G among children with pneumonia in Ji'nan, China. BMC Pediatrics
18, 383.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6282317</ArticleId>
            <ArticleId IdType="pubmed">30518371</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guiso N
et al. (2011) What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories. European Journal of Clinical Microbiology &amp; Infectious Diseases: Official Publication of the European Society of Clinical Microbiology
30, 307–312.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3034915</ArticleId>
            <ArticleId IdType="pubmed">21069406</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barkoff A-M, Gröndahl-Yli-Hannuksela K and He Q (2015) Seroprevalence studies of pertussis: what have we learned from different immunized populations. Pathogens and Disease
73, 1–12. doi: 10.1093/femspd/ftv050.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/femspd/ftv050</ArticleId>
            <ArticleId IdType="pubmed">26208655</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Monereo-Sánchez J
et al. (2021) Vaccination history for diphtheria and tetanus is associated with less severe COVID-19. bioRxiv. medRxiv.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8529993</ArticleId>
            <ArticleId IdType="pubmed">34691063</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maple PA
et al. (1995) Diphtheria immunity in UK blood donors. The Lancet
345, 963–965.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7715300</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>di Giovine P
et al. (2013) Comparative seroepidemiology of diphtheria in six European countries and Israel. Epidemiology and Infection
141, 132–142.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22361223</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Amanna IJ, Carlson NE and Slifka MK (2007) Duration of humoral immunity to common viral and vaccine antigens. The New England Journal of Medicine
357, 1903–1915.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17989383</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Prendergast AJ (2015) Malnutrition and vaccination in developing countries. Philosophical Transactions of the Royal Society B: Biological Sciences
370, 20140141.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4527386</ArticleId>
            <ArticleId IdType="pubmed">25964453</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zimmermann P and Curtis N (2019) Factors that influence the immune response to vaccination. Clinical Microbiology Reviews
32, 1–50.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6431125</ArticleId>
            <ArticleId IdType="pubmed">30867162</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stoffel NU
et al. (2020) Iron deficiency anemia at time of vaccination predicts decreased vaccine response and iron supplementation at time of vaccination increases humoral vaccine response: a birth cohort study and a randomized trial follow-up study in Kenyan infants. Frontiers in Immunology
11, 1–16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7369313</ArticleId>
            <ArticleId IdType="pubmed">32754150</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mina MJ
et al. (2020) A Global lmmunological Observatory to meet a time of pandemics. eLife.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7292646</ArticleId>
            <ArticleId IdType="pubmed">32510329</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
